⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aminoserine SCHEMBL277836 | 1.00 | — | — | |
| Aminoserine SCHEMBL8333262 | 1.00 | — | — | |
| Aminoserine SCHEMBL853082 | 0.97 | — | — | |
| Aminoserine SCHEMBL853081 | 0.97 | — | — | |
| Aminoserine SCHEMBL5114875 | 0.97 | — | — | |
| Aminoserine SCHEMBL8506214 | 0.94 | — | — | |
| Aminoserine SCHEMBL15668067 | 0.94 | SLC1A1 (0.37) | — | |
| Aminoserine SCHEMBL8506211 | 0.94 | — | — | |
| Aminoserine SCHEMBL3166789 | 0.89 | SLC1A1 (0.34) | — | |
| Aminoserine SCHEMBL17491742 | 0.89 | LMNA (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 818 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094657-A | Hair waving composition containing amine derivative | — | 2026-05-26 | — | — | CN | claimed |
| CN-121609785-B | Optimized lactoferrin peptide, preparation method thereof and application thereof in preparation of anti-inflammatory and anti-oxidative damage preparations | 中国海洋大学 | 2026-05-19 | — | — | CN | claimed |
| US-12622948-B2 | GLP-1/GIP dual agonists | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2026-05-12 | — | — | US | claimed |
| US-20250296958-A1 | GLYCOSYLATED CYCLIC ENDOMORPHIN ANALOGS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2025-09-25 | — | — | US | claimed |
| EP-4531885-A1 | GLYCOSYLATED CYCLIC ENDOMORPHIN ANALOGS | The Administrators of The Tulane Educational Fund (US) | 2025-04-09 | — | — | EP | claimed |
| CN-119587769-A | Janus hydrogel and preparation method and application thereof | 广东省科学院生物与医学工程研究所 | 2025-03-11 | — | — | CN | claimed |
| US-20240424063-A1 | LONG ACTING GLP-1/GIP DUAL AGONISTS | SUN PHARMACEUTICAL IND LTD (IN) | 2024-12-26 | — | — | US | claimed |
| US-20240400613-A1 | GLP-1/GIP DUAL AGONISTS | SUN PHARMACEUTICAL IND LTD (IN) | 2024-12-05 | — | — | US | claimed |
| CN-119039420-A | Tenipout peptide synthesis method | 恒敬合创生物医药（浙江）有限公司 | 2024-11-29 | — | — | CN | claimed |
| US-20240294595-A1 | GLYCOPEPTIDES AND USES THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2024-09-05 | — | — | US | claimed |
| EP-1104304-A1 | MULTIVALENT AVB3 AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS | G.D. SEARLE & CO. (US) | 2001-06-06 | — | — | EP | claimed |
| EP-1070085-A1 | DUAL A v?b 3? AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS | G.D. SEARLE & CO. (US) | 2001-01-24 | — | — | EP | claimed |
| WO-2000009143-A1 | MULTIVALENT AVB3 AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS | G.D. SEARLE & CO. (US) | 2000-02-24 | — | — | WO | claimed |
| WO-1999051638-A1 | DUAL Avb3 AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS | G.D. SEARLE & CO. (US) | 1999-10-14 | — | — | WO | claimed |
| US-5519000-A | OLIGOPEPTIDE | CENTECOR, INC. (US) | 1996-05-21 | — | — | US | claimed |
| US-5486595-A | Tumor necrosis factor inhibitors | CENTECOR, INC. (US) | 1996-01-23 | — | — | US | claimed |
| WO-1995026744-A1 | TUMOR NECROSIS FACTOR INHIBITORS | CENTOCOR, INC. (US) | 1995-10-12 | — | — | WO | claimed |
| US-5350841-A | Amide derivatives of gangliocides including aminoacids or amino sulfonic acids for nervous system disorders | FIDIA S.P.A. (IT) | 1994-09-27 | — | — | US | claimed |
| US-5215897-A | Reacting amino acid amide with a culture of microorganisms Enterobacter cloacae or Pseudomonas species and mutant strains that produce L-amylase activity | NITTO CHEMICAL INDUSTRIES CO., LTD. (JP) | 1993-06-01 | — | — | US | claimed |
| EP-0203031-A2 | Biologically active lysine containing octapeptides | The Administrators of The Tulane University Educational Fund (US) | 1986-11-26 | — | — | EP | claimed |